Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-10-03 Sale |
2024-10-07 7:38 pm |
CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner |
3,808,000 | $0.10332 | $393,439 | 6,092,000 (Direct) |
View |
2024-09-30 Sale |
2024-10-02 5:02 pm |
CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner |
2,600,000 | $0.11448 | $297,644 | 9,900,000 (Direct) |
View |
2024-07-03 Sale |
2024-09-19 5:01 pm |
CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner |
15,301,068 | $0.30014 | $4,592,487 | 2,444,277 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-03 Option Award |
2025-06-13 07:17 am |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Chief Executive Officer 10% Owner |
154,799 | $3.23 | 174,993 (Indirect) |
View |
Ownership |
2025-05-07 5:35 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Sarborg Ltd 10% Owner |
0 | $0 | 1,853,933 (Direct) |
View |
2025-04-16 Option Award |
2025-04-17 4:05 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
115,194 | $0.8681 | 165,238 (Direct) |
View |
2025-03-30 Option Award |
2025-04-01 9:13 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director |
47,612 | $0.89 | 77,193 (Direct) |
View |
2025-03-30 Option Award |
2025-04-01 9:09 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director |
29,354 | $0.89 | 31,354 (Direct) |
View |
2025-03-30 Option Award |
2025-04-01 9:07 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
32,022 | $0.89 | 35,537 (Direct) |
View |
2025-03-30 Option Award |
2025-04-01 9:04 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
46,629 | $0.89 | 50,044 (Direct) |
View |
2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
Ownership |
2024-12-20 5:05 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Fry Simon Jeremy Director |
0 | $0 | 200,000 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director |
437,976 | $0.0919 | 2,958,287 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A 2034-11-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer |
840,000 | $0.0919 | 840,000 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
299,238 | $0.0919 | 351,510 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A 2034-11-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO |
1,890,000 | $0.0919 | 1,890,000 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
266,594 | $0.0919 | 341,594 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
75,000 | $0 | 341,594 (Direct) |
View |
2024-06-14 Other |
2024-09-19 5:01 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner |
1,100,000 | $0 | 2,444,277 (Indirect) |
View |
Ownership |
2024-08-13 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner |
0 | $0 | 14,500,000 (Direct) |
View |
2024-06-11 Option Award |
2024-06-11 5:56 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
37,272 | $0 | 52,272 (Direct) |
View |
2024-06-11 Option Award |
2024-06-11 5:53 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO |
37,272 | $0 | 37,272 (Direct) |
View |
2024-04-22 Option Award |
2024-04-24 5:00 pm |
2025-04-22 2027-04-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer |
400,664 | $0 | 600,996 (Direct) |
View |
2024-04-22 Option Award |
2024-04-24 5:00 pm |
2025-04-22 2027-04-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Intelmed LLC Director |
504,061 | $0 | 504,061 (Indirect) |
View |
2024-04-22 Option Award |
2024-04-24 5:00 pm |
2025-04-22 2027-04-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
3,000 | $0 | 206,332 (Direct) |
View |
2023-12-01 Option Award |
2023-12-14 5:16 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Director |
223,634 | $5.51 | 223,634 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | McNealey Jennifer Isacoff Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Director |
298,179 | $5.51 | 298,179 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Sragovicz Adam Chief Financial Officer |
74,545 | $0 | 74,545 (Direct) |
View |
2023-09-22 Option Award |
2023-09-26 5:49 pm |
N/A 2028-10-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
15,000 | $11.5 | 30,000 (Direct) |
View |
2023-09-22 Option Award |
2023-09-26 5:49 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
15,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2023-09-26 5:41 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Intelmed LLC Director |
0 | $0 | 2,520,311 (Indirect) |
View |
Ownership |
2023-09-26 5:37 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner |
0 | $0 | 45,593,799 (Direct) |
View |